Hampton Malcolm Garret 4

What Happened

• Hampton Malcolm Garret, a director of IDEAYA Biosciences (IDYA), was granted a derivative award on 2026-06-16 covering 20,000 shares. The award shows $0 cash consideration (acquired at $0.00) — i.e., a compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-16; filing date: 2026-06-18 (timely Form 4 filing).
• Transaction type: Award/Grant of derivative securities (code A); reported as 20,000 shares acquired at $0.00.
• Vesting: Per footnote, 100% of the shares subject to the option vest in full on the earlier of (i) the first anniversary of the grant date or (ii) immediately prior to the next Annual Meeting, provided the director continues service through vesting.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Exercise price or other option terms beyond the vesting schedule were not disclosed in the excerpt.

Context

• This is a typical director compensation award (an option-style grant subject to vesting) and does not represent an immediate market purchase or sale. Such grants are routine for board service; purchases tend to be more direct signals of insider buying interest. The vesting provision means the director must remain in service and/or reach the stated dates before the underlying shares become vested and potentially exercisable.